GPCR
Price
$29.89
Change
-$0.24 (-0.80%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
1.74B
27 days until earnings call
Intraday Buy/Sell Signals
IMTX
Price
$10.57
Change
+$0.40 (+3.93%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
1.24B
33 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

GPCR vs IMTX

Header iconGPCR vs IMTX Comparison
Open Charts GPCR vs IMTXBanner chart's image
Structure Therapeutics
Price$29.89
Change-$0.24 (-0.80%)
Volume$1.6K
Capitalization1.74B
Immatics
Price$10.57
Change+$0.40 (+3.93%)
Volume$11.59K
Capitalization1.24B
GPCR vs IMTX Comparison Chart in %
GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GPCR vs. IMTX commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GPCR is a Hold and IMTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (GPCR: $30.20 vs. IMTX: $10.18)
Brand notoriety: GPCR and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GPCR: 124% vs. IMTX: 58%
Market capitalization -- GPCR: $1.74B vs. IMTX: $1.24B
GPCR [@Biotechnology] is valued at $1.74B. IMTX’s [@Biotechnology] market capitalization is $1.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GPCR’s FA Score shows that 1 FA rating(s) are green whileIMTX’s FA Score has 0 green FA rating(s).

  • GPCR’s FA Score: 1 green, 4 red.
  • IMTX’s FA Score: 0 green, 5 red.
According to our system of comparison, GPCR is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GPCR’s TA Score shows that 2 TA indicator(s) are bullish while IMTX’s TA Score has 4 bullish TA indicator(s).

  • GPCR’s TA Score: 2 bullish, 3 bearish.
  • IMTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IMTX is a better buy in the short-term than GPCR.

Price Growth

GPCR (@Biotechnology) experienced а +6.26% price change this week, while IMTX (@Biotechnology) price change was +8.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.44%. For the same industry, the average monthly price growth was +17.42%, and the average quarterly price growth was +81.94%.

Reported Earning Dates

GPCR is expected to report earnings on Nov 12, 2025.

IMTX is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($1.74B) has a higher market cap than IMTX($1.24B). IMTX YTD gains are higher at: 43.122 vs. GPCR (11.357). IMTX has higher annual earnings (EBITDA): -58.05M vs. GPCR (-218.56M). GPCR has more cash in the bank: 786M vs. IMTX (478M). GPCR has less debt than IMTX: GPCR (7.68M) vs IMTX (17.1M). IMTX has higher revenues than GPCR: IMTX (130M) vs GPCR (0).
GPCRIMTXGPCR / IMTX
Capitalization1.74B1.24B141%
EBITDA-218.56M-58.05M377%
Gain YTD11.35743.12226%
P/E RatioN/A27.61-
Revenue0130M-
Total Cash786M478M164%
Total Debt7.68M17.1M45%
FUNDAMENTALS RATINGS
IMTX: Fundamental Ratings
IMTX
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
88
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
61
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GPCRIMTX
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
68%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IBNCX25.340.02
+0.08%
Macquarie Balanced Fund Class C
SCORX18.96N/A
N/A
Saturna Core
NBGAX60.28N/A
N/A
Neuberger Berman Genesis Adv
PGIAX38.79-0.02
-0.05%
Putnam Focused Equity A
MYICX9.63-0.04
-0.41%
NYLI WMC International Research Eq Cl C

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been loosely correlated with CLDX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GPCR jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
+0.03%
CLDX - GPCR
43%
Loosely correlated
-2.47%
TERN - GPCR
43%
Loosely correlated
-1.40%
ARWR - GPCR
42%
Loosely correlated
-0.80%
SYRE - GPCR
42%
Loosely correlated
+11.02%
IMTX - GPCR
42%
Loosely correlated
+0.85%
More

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IDYA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+0.85%
IDYA - IMTX
53%
Loosely correlated
+1.12%
SYRE - IMTX
50%
Loosely correlated
+11.02%
RLAY - IMTX
49%
Loosely correlated
-3.99%
OCUL - IMTX
49%
Loosely correlated
-5.40%
IMNM - IMTX
49%
Loosely correlated
-1.26%
More